The first germline mutations identified in the CHEK2 gene were associated with Li-Fraumeni syndrome (MIM# 609265), a disease characterised by high occurrences of sarcomas, breast cancer, brain tumours, acute leukaemia and adrenocortical tumours [8]. This evidence concerns the gene CHEK2 and breast carcinoma.